Arthur Laffer has resigned from the board of Oxigene Inc., where had served since 1998. Mr. Laffer, a reknowned economist, is credited with being one of the originators of supply side economics.
Oxigene Inc. is a developement stage stage biotechnology company headquartered in South San Francisco, California. Oxigene is currently developing novel therapeutics to treat cancer and eye diseases. Oxigene's ZYBRESTAT is currently in Phase 2 development.
Oxigene trades under the symbol OXGN on the Nasdaq. OXGN stock price fell 4.07% to close at $1.18 in trading on Monday.
